[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
JAMA Clinical Guidelines Synopsis
November 3, 2015

Evaluation of Patients With Asymptomatic Microhematuria

Author Affiliations
  • 1Wilson Medical Group, Wilson, North Carolina
  • 2Department of Medicine, University of Chicago, Chicago, Illinois
JAMA. 2015;314(17):1865-1866. doi:10.1001/jama.2015.13711

Urinary tract malignancies (primarily renal cell carcinoma and adenocarcinoma of the bladder) are common. In the United States, bladder cancer is the fifth most common cancer, accounting for 4.5% of new cases.1,2 Risk factors include increasing age, white race, and history of smoking.2 Hematuria is the clinical presentation of 90% of cases of bladder cancer, although most cases of hematuria are unrelated to malignancy.2 One retrospective study found urinary tract tumors in 10% of patients presenting with gross hematuria and 3% of patients presenting with microhematuria.3

First Page Preview View Large
First page PDF preview
First page PDF preview
×